Literature DB >> 7423333

[Experimental dermatitis caused by Pityrosporum ovale and (or) Pityrosporum orbiculare in the guinea pig and the mouse].

E Drouhet, D Dompmartin, A Papachristou-Moraiti, P Ravisse.   

Abstract

An experimental dermatitis was established for the guinea pig and Swiss white mouse by topical application of cultures of Pityrosporum ovale, isolated from pityriasis capitis and from P. arbiculare isolated from pityriasis versicolor. Histology showed the development of the yeasts in the stratum corneum, with hyperkeratosis at the follicular ostium and in the pilous bulb: the clinical and histological appearances resembled human seborrheic dermatitis. The nude (nu/nu) mouse, the hair-less mouse and the nude rat were not susceptible to this experimental infection, probably because of the dystrophy of their pilous follicles and sebaceous glands. The experimental model permitted evaluation of antifungal agents. The Pityrosporum dermatitis disappeared rapidly after topical application of econazole or amphotericin B. No pathological differences were observed between the strains tested.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7423333

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  4 in total

Review 1.  Human infections due to Malassezia spp.

Authors:  M J Marcon; D A Powell
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

2.  Epidemiologic Study of Malassezia Yeasts in Seborrheic Dermatitis Patients by the Analysis of 26S rDNA PCR-RFLP.

Authors:  Byung Ho Oh; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2010-05-17       Impact factor: 1.444

Review 3.  Malassezia Yeasts in Veterinary Dermatology: An Updated Overview.

Authors:  Jacques Guillot; Ross Bond
Journal:  Front Cell Infect Microbiol       Date:  2020-02-28       Impact factor: 5.293

4.  Addressing Justified Vaccine Hesitancy in the Black Community.

Authors:  Cato T Laurencin
Journal:  J Racial Ethn Health Disparities       Date:  2021-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.